Sera Prognostics (SERA) EBT Margin Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -464.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 772.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 233.00 |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 | -5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.52 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -5.05 Mn |
| Jun 30, 2025 | -3.64 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | -995,394.00 |
| Jun 30, 2024 | -2.71 Mn |
| Dec 31, 2023 | -224,949.00 |
| Sep 30, 2023 | -575,181.00 |
| Jun 30, 2023 | 592,411.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.01 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 4.03 Mn |
| Sep 30, 2021 | 5.84 Mn |
| Jun 30, 2021 | 4.14 Mn |